To the Editor: Australia's National Notifiable Diseases Surveillance System (NNDSS) is used to monitor trends in 58 communicable diseases or conditions. The incidence of notifiable diseases can be decreased by public health action. Some diseases require rapid local responses, such as outbreaks of vaccine-preventable or foodborne diseases. Upward trends in the incidence of other notifiable diseases — for example, tuberculosis, sexually transmitted infections and bloodborne viruses — can be managed by less-rapid responses. The NNDSS exists not for data collection per se, but for public health action.
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
- 1. Shield JM, Page W. Effective diagnostic tests and anthelmintic treatment for Strongyloides stercoralis make community control feasible. P N G Med J 2008; 51: 105-119.
- 2. Mounsey K, Kearns T, Rampton M, et al. Use of dried blood spots to define antibody response to the Strongyloides stercoralis recombinant antigen NIE. Acta Tropica 2014; 138: 78-82.
- 3. Shield J. Mapping Strongyloides stercoralis in Australia: fill in the gaps. Poster presented at the Ninth National Workshop on Strongyloidiasis. Proceedings of the Rural Medicine Australia 2014 Conference; Oct 30-Nov 1; Sydney, Australia.
- 4. Johnston FH, Morris PS, Speare R, et al. Strongyloidiasis: a review of the evidence for Australian practitioners. Aust J Rural Health 2005; 13: 247-254.
- 5. Miller A, Smith M, Judd J, et al. Strongyloides stercoralis: systematic review of barriers to controlling strongyloidiasis for Australian Indigenous communities. PLOS Negl Trop Dis 2014; 8: e3141.
- 6. Speare R, Durrheim D. Strongyloides serology — useful for diagnosis and management of strongyloidiasis in rural Indigenous populations, but important gaps in knowledge remain. Rural Remote Health 2004; 4: 264.
- 7. Page W. Dempsey K, McCarthy JS. Utility of serological follow-up of chronic strongyloidiasis after anthelmintic chemotherapy. Trans R Soc Trop Med Hyg 2006; 100: 1056-1064.
We thank Jenni Judd and Jennifer Shield for their contributions to the writing of this letter, and the Australian Research Council Discovery Indigenous Researchers Development program for support.
No relevant disclosures.